Thymopentin in the treatment of juvenile chronic arthritis

M. Bardare, F. Corona, M. T. Ogliari, E. Cohen

Research output: Contribution to journalArticlepeer-review


An immunological imbalance is probably one of the major pathogenetic causes of rheumatoid arthritis in adults as well as in children. This aspect is the rationale for the use of immuno-modulating drugs. In our study we evaluated the effects of intravenously administered thymopentin on systemic and local features in 10 children affected with systemic onset juvenile chronic arthritis (JCA). We also considered the effects of intra-articular thymopentin in 3 children affected with pauciarticular onset JCA.

Original languageEnglish
Pages (from-to)89-93
Number of pages5
JournalClinical and Experimental Rheumatology
Issue number1
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Immunology
  • Rheumatology


Dive into the research topics of 'Thymopentin in the treatment of juvenile chronic arthritis'. Together they form a unique fingerprint.

Cite this